EastWest Bioscience Inc.
HBOSF · OTC
7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|
| Market Cap | $1,689 | $1,606 | $1,492 |
| - Cash | $1,057 | $107 | $55 |
| + Debt | $2,420 | $2,268 | $1,946 |
| Enterprise Value | $3,052 | $3,767 | $3,382 |
| Revenue | $627 | $923 | $1,397 |
| % Growth | -32% | -34% | – |
| Gross Profit | $28 | $101 | $356 |
| % Margin | 4.5% | 11% | 25.5% |
| EBITDA | -$1,649 | -$1,731 | -$3,134 |
| % Margin | -262.9% | -187.6% | -224.4% |
| Net Income | -$1,607 | -$1,132 | -$3,667 |
| % Margin | -256.2% | -122.7% | -262.5% |
| EPS Diluted | -0.017 | -0.014 | -0.046 |
| % Growth | -25.7% | 70.8% | – |
| Operating Cash Flow | -$689 | -$324 | -$2,456 |
| Capital Expenditures | -$9 | -$1 | -$27 |
| Free Cash Flow | -$699 | -$326 | -$2,484 |